OBJECTIVES: To assess:1) if HIV screening with rapid tests in neighbourhoods with a substantial African community is feasible and acceptable among GPs and patients; 2) HIV seroprevalence. METHODS: Multicenter prospective study with 10 trained physicians. Use of HIV standard test and INSTI Ultrarapid test. INCLUSION CRITERIA: MSM, sex worker, multiple sexual partners, having returned or coming from a country with high HIV prevalence, IVDU, Indicator conditions as defined by HIV Indicator Diseases across Europe Study, having an AIDS-defining illness, having had a recent pregnancy or abortion; or presenting other risks. RESULTS: From August 2010 to August 2011, 10 trained GPs offered an HIV test to 224 patients: 51% ♀, 48% ♂, 43% Caucasians, 45% Africans. INCLUSION CRITERIA: 32% "high risk group", 9% returning from an endemic country, 29% with an indicator condition; 12 patients (6%) refused the standard test. The INSTI was offered to 217(97%), 197 performed with 2 reactive rapid tests confirmed. The seroprevalence according to ethnic origin was 0% among Caucasians and 2.2% among Africans and was 1.5% among patients with an indicator condition. 1087 consecutive consultations of the same GPs were recorded: 42% patients had ≥ 1 inclusion criteria among which 41% of offered tests, that is to say 59% of "missed opportunities". The reasons for not offering the test as recorded for 55% of patients:"not indicated" 44.5%, "no time" 33%, "impossible to propose" 15%, test completed previously 11%, known HIV-positive 4%. CONCLUSIONS: Standard and rapid tests are well received by patients but were usually not offered by doctors who have been trained.
OBJECTIVES: To assess:1) if HIV screening with rapid tests in neighbourhoods with a substantial African community is feasible and acceptable among GPs and patients; 2) HIV seroprevalence. METHODS: Multicenter prospective study with 10 trained physicians. Use of HIV standard test and INSTI Ultrarapid test. INCLUSION CRITERIA: MSM, sex worker, multiple sexual partners, having returned or coming from a country with high HIV prevalence, IVDU, Indicator conditions as defined by HIV Indicator Diseases across Europe Study, having an AIDS-defining illness, having had a recent pregnancy or abortion; or presenting other risks. RESULTS: From August 2010 to August 2011, 10 trained GPs offered an HIV test to 224 patients: 51% ♀, 48% ♂, 43% Caucasians, 45% Africans. INCLUSION CRITERIA: 32% "high risk group", 9% returning from an endemic country, 29% with an indicator condition; 12 patients (6%) refused the standard test. The INSTI was offered to 217(97%), 197 performed with 2 reactive rapid tests confirmed. The seroprevalence according to ethnic origin was 0% among Caucasians and 2.2% among Africans and was 1.5% among patients with an indicator condition. 1087 consecutive consultations of the same GPs were recorded: 42% patients had ≥ 1 inclusion criteria among which 41% of offered tests, that is to say 59% of "missed opportunities". The reasons for not offering the test as recorded for 55% of patients:"not indicated" 44.5%, "no time" 33%, "impossible to propose" 15%, test completed previously 11%, known HIV-positive 4%. CONCLUSIONS: Standard and rapid tests are well received by patients but were usually not offered by doctors who have been trained.
Authors: Rafael Carlos Puentes Torres; Cristina Aguado Taberné; Luis Ángel Pérula de Torres; José Espejo Espejo; Cristina Castro Fernández; Luis Fransi Galiana Journal: Aten Primaria Date: 2017-05-10 Impact factor: 1.137
Authors: S Desai; L Tavoschi; A K Sullivan; L Combs; D Raben; V Delpech; S F Jakobsen; A J Amato-Gauci; S Croxford Journal: HIV Med Date: 2019-11-14 Impact factor: 3.180
Authors: S Herbst de Cortina; C C Bristow; S K Vargas; D G Perez; K A Konda; C F Caceres; J D Klausner Journal: J Clin Microbiol Date: 2016-05-04 Impact factor: 5.948
Authors: Jessika Deblonde; André Sasse; Julia Del Amo; Fiona Burns; Valerie Delpech; Susan Cowan; Michele Levoy; Lilana Keith; Anastasia Pharris; Andrew Amato-Gauci; Teymur Noori Journal: BMC Public Health Date: 2015-12-10 Impact factor: 3.295
Authors: Tom Platteau; Katrien Fransen; Ludwig Apers; Chris Kenyon; Laura Albers; Tine Vermoesen; Jasna Loos; Eric Florence Journal: J Med Internet Res Date: 2015-09-01 Impact factor: 5.428
Authors: Nitika Pant Pai; Tiago Chiavegatti; Rohit Vijh; Nicolaos Karatzas; Jana Daher; Megan Smallwood; Tom Wong; Nora Engel Journal: Point Care Date: 2017-11-14
Authors: Jessika Deblonde; Dominique Van Beckhoven; Jasna Loos; Nicole Boffin; André Sasse; Christiana Nöstlinger; Virginie Supervie Journal: BMC Public Health Date: 2018-10-22 Impact factor: 3.295
Authors: Hanne Apers; Christiana Nöstlinger; Dominique Van Beckhoven; Jessika Deblonde; Ludwig Apers; Katleen Verheyen; Jasna Loos Journal: Health Promot Int Date: 2020-04-01 Impact factor: 2.483